Maven Securities LTD Praxis Precision Medicines, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.83 - $1.18 $1.12 Million - $1.59 Million	1,351,442 New	1,351,442 $1.55 Million
Q2 2021 Aug 16, 2021	SELL	$18.28 - $33.05 $890,108 - $1.61 Million	-48,693 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.34 - $60.2 $884,953 - $1.82 Million	30,162 Added 162.77%	48,693 $1.52 Million
Q4 2020 Feb 12, 2021	BUY	$27.25 - $55.82 $504,969 - $1.03 Million	18,531 New	18,531 $1.03 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.